T Lymphocytes in Parkinson’s Disease
Authors:
Open Access
- 27 September 2022
- journal article
- review article
- Published by SAGE Publications in Journal of Parkinson’s Disease
- Vol. 12 (s1) , S65-S74
Abstract
T cells are key mediators of both humoral and cellular adaptive immune responses, and their role in Parkinson’s disease (PD) is being increasingly recognized. Several lines of evidence have highlighted how T cells are involved in both the central nervous system and the periphery, leading to a profound imbalance in the immune network in PD patients. This review discusses the involvement of T cells in both preclinical and clinical studies, their importance as feasible biomarkers of motor and non-motor progression of the disease, and recent therapeutic strategies addressing the modulation of T cell response.Keywords
This publication has 75 references indexed in Scilit:
- CD4+ Regulatory and Effector/Memory T Cell Subsets Profile Motor Dysfunction in Parkinson’s DiseaseJournal of Neuroimmune Pharmacology, 2012
- Human leukocyte antigen variation and Parkinson’s diseaseParkinsonism & Related Disorders, 2011
- Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's diseaseNature Genetics, 2010
- Regulatory T Cells Attenuate Th17 Cell-Mediated Nigrostriatal Dopaminergic Neurodegeneration in a Model of Parkinson’s DiseaseThe Journal of Immunology, 2010
- Microglia Acquire Distinct Activation Profiles Depending on the Degree of α-Synuclein Neuropathology in a rAAV Based Model of Parkinson's DiseasePLOS ONE, 2010
- Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson diseaseJournal of Clinical Investigation, 2008
- Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson’s diseaseJournal of Leukocyte Biology, 2007
- Alterations of T-lymphocyte populations in Parkinson diseaseParkinsonism & Related Disorders, 2005
- Blood–brain barrier dysfunction in parkinsonian midbrain in vivoAnnals of Neurology, 2005
- Human T Regulatory Cells Can Use the Perforin Pathway to Cause Autologous Target Cell DeathImmunity, 2004